Avadel Pharma (AVDL) Misses Q2 EPS by 65c
Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($1.07), $0.65 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.
Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($1.07), $0.65 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.